Journal article

A mutation outside the dimerization domain causing atypical STING-associated vasculopathy with onset in infancy

RG Saldanha, KR Balka, S Davidson, BK Wainstein, M Wong, R Macintosh, CKC Loo, MA Weber, V Kamath, F Moghaddas, D De Nardo, PE Gray, SL Masters

Frontiers in Immunology | FRONTIERS MEDIA SA | Published : 2018

Open access

Abstract

Background: Mutations in the gene encoding stimulator of interferon genes (STING) underlie a type I interferon (IFN) associated disease, STING-associated vasculopathy with onset in infancy (SAVI). Patients suffer cutaneous vasculopathy and interstitial lung disease, but are not known to suffer life-threatening infection. Case: We describe a child who presented with Pneumocystis jirovecii pneumonia in early life, from which he recovered. He went on to suffer failure to thrive, developmental delay, livedo reticularis, and vesicular rash, but without cutaneous vasculitis, and with normal C-reactive protein and erythrocyte sedimentation rates. At 3 years of age, he developed life-threatening pul..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council


Funding Acknowledgements

SM acknowledges funding from NHMRC grants (1144282, 1142354, and 1099262), The Sylvia and Charles Viertel Foundation, HHMI-Wellcome International Research Scholarship, and Glaxosmithkline. SD acknowledges funding from NHMRC ECF: GNT1143412. Costco Wholesale Australia and the Fundraising department of The Children's Hospital at Westmead provided generous support to enable genomic sequencing through a SCHN rare disease genomics initiative.